pioneering pharmaceuticals
making pharmaceuticals more affordable, more available, and better than before
Innovative solutions along the entire pharmaceutical value chain
As part of the TIEFENBACHER GROUP, a 100% family-owned leading health care company, we provide solutions throughout the entire life cycle of a pharmaceutical product. We develop, manufacture, and register innovative as well as generic drugs for our B2B customers. The world´s most trusted brands count on our high excellence in creating best-in-class-dossiers and our ability to manage complex launches in over 80 countries worldwide. Our own laboratories and manufacturing sites empower us to build up efficient supply chains resulting in best value for money for our customers.
There is one purpose driving TIEFENBACHER´s over 600 employees day by day: improving the life of millions of patients worldwide by making pharmaceuticals more affordable, more available, and better than before.
Best Value: affordable high-quality pharmaceuticals worldwide
Our Business Model
We develop, manufacture, and register innovative as well as generic drugs and license them out to marketing partners worldwide. Advance tomorrow’s medicine with us!
What comes out: The Future
creating value for patients by bringing Innovations to life
Our Vision
Improving the life of millions of patientsworldwide by making a differencein tomorrow´s health.
Our Mission
Creating high-quality pharmaceuticals forthe most trusted brands - more affordable,more available, and better than before.
Tiefenbacher group company values:
The courage to shape a better futureAlways one step ahead – this is how we work, this is how we think
Our history: Pioneering Healthcare since 1963
Over 55 years track record of industry firsts
Founded in 1963 as the world’s first exclusive agency for active pharmaceuticals ingredients (API), TIEFENBACHER has been grown into a leading health care company providing innovative and best-in-class solutions along the entire pharmaceutical value chain. Representing API producers has provided the foundation for TIEFENBACHER´s growth into a fully fledged pharmaceutical company – capable of developing, registering, and supplying finished dosage form (FDF) pharmaceuticals to marketing organizations worldwide. In over 55 years of our company history we have shown an outstanding track record in anticipating new developments as well as launching new businesses.
At a glance: TIEFENBACHER GROUP milestones
Foundation by Alfred E. Tiefenbacher in Hamburg
Foundation by Alfred E. Tiefenbacher in Hamburg
3rd Employee
3rd Employee
Move to new address in villa on Harvestehuder Weg
Move to new address in villa on Harvestehuder Weg
First generic drug development of finished dosage form (FDF)
First generic drug development of finished dosage form (FDF)
First EU marketing authorization under own name
First EU marketing authorization under own name
Move to new headquarters at port of Hamburg
Move to new headquarters at port of Hamburg
Opening of AET Labs (India)
Opening of AET Labs (India)
Acquisition of Delorbis Pharmaceuticals manufacturing site (Cyprus)
Acquisition of Delorbis Pharmaceuticals manufacturing site (Cyprus)
Celebration of the 50th anniversary of Tiefenbacher Group
Celebration of the 50th anniversary of Tiefenbacher Group
Foundation of AET Medical Products
Foundation of AET Medical Products
First NCE submission under own name
First NCE submission under own name
First FDF US submission under own name
First FDF US submission under own name
FDA approval of AET Labs manufacturing site
FDA approval of AET Labs manufacturing site
First medical device CE certification
First medical device CE certification
Our founder Alfred E. Tiefenbacher
Pioneer of the pharmaceutical industry
Our entrepreneurial spirit is firmly anchored in our founder and owner family since 1963.
The foundation for this success story was the pioneer spirit of the company´s founder and namesake Alfred E. Tiefenbacher (+1993). Until today his unique entrepreneur mind is one important pillar of TIEFENBACHER´s corporate culture: our about 600 employees are always challenging the status quo and striving for new patient orientated solutions – in terms of business models as well as concrete products and services for our customers and partners.
AET Management
our managing directors
AET, as a part of the TIEFENBACHER GROUP, is led by a seasoned team of executives. Their cumulative knowledge and combined professional backgrounds add up to unparalleled leadership that keeps our company always a step ahead of the industry and in sync with our customers ‘ needs.
Dr. Kristian Ruepp
Kristian has held various positions in the pharmaceutical industry. He was able to contribute to the development, production and control up to the international marketing of pharmaceuticals – recently as managing director of an internationally operating pharmaceutical company. Kristian joined Alfred E. Tiefenbacher in 2018 and is responsible for the pharmaceutical functions and marketing.
Kristian is married and father of three.
Oliver Schrader
Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined the TIEFENBACHER GROUP in 2016 and is overlooking all commercial topics.
Oliver is married and a father of three.
Global Presence –in over 80 countries
Our path to profitable growth
Tiefenbacher Group
Webcam Hamburg
Contact –Partner with us
As the builders of the future, we are working to improve people´s lives.By thinking beyond healthcare.
ALFRED E. TIEFENBACHER (GmbH & Co. KG)
Van-der-Smissen-Strasse 1
22767 Hamburg
Germany
Phone: +49 40 – 44 18 09 – 0
Fax: +49 40 – 44 18 09 – 26
Mail: info@aet.eu